Cooper Research and Development Expenses 2010-2024 | COO
Cooper annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Cooper research and development expenses for the quarter ending October 31, 2024 were $0.038B, a 2.72% increase year-over-year.
- Cooper research and development expenses for the twelve months ending October 31, 2024 were $0.155B, a 12.88% increase year-over-year.
- Cooper annual research and development expenses for 2024 were $0.155B, a 12.88% increase from 2023.
- Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
- Cooper annual research and development expenses for 2022 were $0.11B, a 18.99% increase from 2021.
Cooper Annual Research and Development Expenses
(Millions of US $) |
| 2024 |
$155 |
| 2023 |
$137 |
| 2022 |
$110 |
| 2021 |
$93 |
| 2020 |
$93 |
| 2019 |
$87 |
| 2018 |
$85 |
| 2017 |
$69 |
| 2016 |
$65 |
| 2015 |
$70 |
| 2014 |
$66 |
| 2013 |
$59 |
| 2012 |
$52 |
| 2011 |
$44 |
| 2010 |
$35 |
| 2009 |
$33 |
Cooper Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-10-31 |
$38 |
| 2024-07-31 |
$39 |
| 2024-04-30 |
$39 |
| 2024-01-31 |
$40 |
| 2023-10-31 |
$37 |
| 2023-07-31 |
$37 |
| 2023-04-30 |
$33 |
| 2023-01-31 |
$32 |
| 2022-10-31 |
$29 |
| 2022-07-31 |
$29 |
| 2022-04-30 |
$26 |
| 2022-01-31 |
$26 |
| 2021-10-31 |
$26 |
| 2021-07-31 |
$25 |
| 2021-04-30 |
$21 |
| 2021-01-31 |
$21 |
| 2020-10-31 |
$26 |
| 2020-07-31 |
$22 |
| 2020-04-30 |
$24 |
| 2020-01-31 |
$22 |
| 2019-10-31 |
$23 |
| 2019-07-31 |
$22 |
| 2019-04-30 |
$21 |
| 2019-01-31 |
$21 |
| 2018-10-31 |
$23 |
| 2018-07-31 |
$23 |
| 2018-04-30 |
$21 |
| 2018-01-31 |
$19 |
| 2017-10-31 |
$19 |
| 2017-07-31 |
$18 |
| 2017-04-30 |
$17 |
| 2017-01-31 |
$16 |
| 2016-10-31 |
$18 |
| 2016-07-31 |
$16 |
| 2016-04-30 |
$17 |
| 2016-01-31 |
$15 |
| 2015-10-31 |
$18 |
| 2015-07-31 |
$18 |
| 2015-04-30 |
$17 |
| 2015-01-31 |
$16 |
| 2014-10-31 |
$18 |
| 2014-07-31 |
$16 |
| 2014-04-30 |
$16 |
| 2014-01-31 |
$16 |
| 2013-10-31 |
$16 |
| 2013-07-31 |
$15 |
| 2013-04-30 |
$14 |
| 2013-01-31 |
$14 |
| 2012-10-31 |
$14 |
| 2012-07-31 |
$13 |
| 2012-04-30 |
$13 |
| 2012-01-31 |
$11 |
| 2011-10-31 |
$12 |
| 2011-07-31 |
$12 |
| 2011-04-30 |
$10 |
| 2011-01-31 |
$10 |
| 2010-10-31 |
$10 |
| 2010-07-31 |
$9 |
| 2010-04-30 |
$9 |
| 2010-01-31 |
$8 |
| 2009-10-31 |
$8 |
| 2009-07-31 |
$8 |
| 2009-04-30 |
$10 |
| 2009-01-31 |
$7 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$18.615B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
